Uploaded on Oct 27, 2020
The major players covered in the global anti-parkinson drugs market are GlaxoSmithKline plc, Pfizer, Merck, Novartis, Roche, UCB S.A, Teva Pharmaceuticals, AbbVie Inc.
Anti-Parkinson Drugs Global Market Report 2020-30 COVID-19 Growth And Change
Anti-Parkinson Drugs Global Market Report
2020-30: COVID-19 Growth And Change
www.tbrc.info Email: [email protected] © The Business Research Company. All rights
reserved.
Anti-Parkinson Drugs Market
Characteristics:
• The global anti-Parkinson drugs market is expected to decline from $4.23 billion in 2019 to $4.12
billion in 2020 at a compound annual growth rate (CAGR) of -2.62%. The decline is mainly due to the
COVID-19 outbreak that has led to restrictive containment measures involving social distancing,
remote working, and the closure of industries and other commercial activities resulting in operational
challenges. The entire supply chain has been disrupted, impacting the market negatively. The market
is then expected to recover and reach $5.04 billion in 2023 at a CAGR of 7.01%.
• The Business Research Company’s latest report Anti-Parkinson Drugs Global Market Report 2020
covers Anti-Parkinson Drugs market drivers, Anti-Parkinson Drugs market trends, Anti-Parkinson
Drugs market segments, Anti-Parkinson Drugs market growth rate, Anti-Parkinson Drugs market major
players, and Anti-Parkinson Drugs market size. The report provides in-depth analysis of the impact of
COVID-19 on the Anti-Parkinson Drugs industry, along with revised market numbers due to the effects
of the coronavirus.
• The major regions included in the report are Asia-Pacific, Western Europe, Eastern Europe, North
America, South America, Middle East, and Africa.
Click Here To View Complete Report
2 © The Business Research Company. All rights reserved.
Major Key Players:
GlaxoSmithKline plc,
Pfizer,
Merck,
Novartis,
Roche,
UCB S.A,
Teva Pharmaceuticals
Click Here To Get A Sample Report
3 © The Business Research Company. All rights reserved.
Table Of Content
1. Executive Summary
2. Anti-Parkinson Drugs Market Characteristics
3. Anti-Parkinson Drugs Market Size And Growth
4. Anti-Parkinson Drugs Market Segmentation
5. Anti-Parkinson Drugs Market Regional And Country Analysis
…..
26. Key Mergers And Acquisitions In The Anti-Parkinson Drugs Market
27. Anti-Parkinson Drugs Market Trends And Strategies
28. Anti-Parkinson Drugs Market Future Outlook and Potential Analysis
29. Appendix
Click Here To Get A Sample Report
4 The Business Research Company. All rights reserved.
Get In Touch
Whatever your need be, at The
Business Research Company we
provide research consulting solutions
for businesses, government agencies
consultancies, and market research
companies.
5 © The Business Research Company. All rights reserved.
Europe Asia Americas
The Business Research Company The Business Research Company, The Business Research Company
47 Anchorage Point, Horizon Avenue, 625 South Avenue, Apt B204,
42 Cuba Street, Canary Wharf, 8-2-603/b/s/1/2 Secane, Philadelphia, PA 19018,
London, England, Road Number 10 USA
E14 8NE. Banjara Hills +1 3156230293
+44 207 1930 708 Hyderabad (India) Email: [email protected]
Email: [email protected] 500033 www.tbrc.info
www.tbrc.info ++91 8897263534
Email: [email protected]
www.tbrc.info
6 © The Business Research Company. All rights reserved.
Comments